25 XP   0   0   10

OptiNose
Buy, Hold or Sell?

Let's analyse Optinose together

PenkeI guess you are interested in OptiNose. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of OptiNose. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about OptiNose

I send you an email if I find something interesting about OptiNose.

Quick analysis of Optinose (30 sec.)










What can you expect buying and holding a share of Optinose? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
9.7%

What is your share worth?

Current worth
$-0.77
Expected worth in 1 year
$-1.03
How sure are you?
29.0%

+ What do you gain per year?

Total Gains per Share
$-0.27
Return On Investment
-18.0%

For what price can you sell your share?

Current Price per Share
$1.48
Expected price per share
$1.16 - $2.04
How sure are you?
50%

1. Valuation of Optinose (5 min.)




Live pricePrice per Share (EOD)

$1.48

Intrinsic Value Per Share

$7.09 - $8.76

Total Value Per Share

$6.32 - $7.99

2. Growth of Optinose (5 min.)




Is Optinose growing?

Current yearPrevious yearGrowGrow %
How rich?-$86.6m-$58.9m-$17.9m-23.4%

How much money is Optinose making?

Current yearPrevious yearGrowGrow %
Making money-$8.8m-$19.2m$10.4m118.2%
Net Profit Margin-60.3%-105.9%--

How much money comes from the company's main activities?

3. Financial Health of Optinose (5 min.)




What can you expect buying and holding a share of Optinose? (5 min.)

Welcome investor! Optinose's management wants to use your money to grow the business. In return you get a share of Optinose.

What can you expect buying and holding a share of Optinose?

First you should know what it really means to hold a share of Optinose. And how you can make/lose money.

Speculation

The Price per Share of Optinose is $1.48. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Optinose.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Optinose, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.77. Based on the TTM, the Book Value Change Per Share is $-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Optinose.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.09-6.0%-0.08-5.3%-0.17-11.2%-0.18-12.1%-0.18-12.1%
Usd Book Value Change Per Share-0.08-5.4%-0.07-4.5%-0.08-5.2%-0.09-6.2%-0.02-1.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.042.7%0.032.0%
Usd Total Gains Per Share-0.08-5.4%-0.07-4.5%-0.08-5.2%-0.05-3.5%0.000.3%
Usd Price Per Share1.29-1.42-2.91-4.12-5.41-
Price to Earnings Ratio-3.65-0.80--4.60--4.39--5.50-
Price-to-Total Gains Ratio-16.16--3.16--14.54--14.49--14.75-
Price to Book Ratio-1.68--2.10--5.57-7.21-6.80-
Price-to-Total Gains Ratio-16.16--3.16--14.54--14.49--14.75-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.48
Number of shares675
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.04
Usd Book Value Change Per Share-0.07-0.09
Usd Total Gains Per Share-0.07-0.05
Gains per Quarter (675 shares)-44.91-34.75
Gains per Year (675 shares)-179.66-139.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-180-190107-246-149
20-359-370214-492-288
30-539-550321-738-427
40-719-730428-984-566
50-898-910535-1230-705
60-1078-1090641-1476-844
70-1258-1270748-1721-983
80-1437-1450855-1967-1122
90-1617-1630962-2213-1261
100-1797-18101069-2459-1400

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.019.00.05.0%3.028.00.09.7%3.028.00.09.7%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%9.020.02.029.0%9.020.02.029.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%2.00.018.010.0%3.00.028.09.7%3.00.028.09.7%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%9.020.02.029.0%9.020.02.029.0%

Fundamentals of Optinose

About OptiNose

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania.

Fundamental data was last updated by Penke on 2024-03-21 02:25:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of OptiNose.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Optinose earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Optinose to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -50.2% means that $-0.50 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of OptiNose:

  • The MRQ is -50.2%. The company is making a huge loss. -2
  • The TTM is -60.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-50.2%TTM-60.3%+10.1%
TTM-60.3%YOY-105.9%+45.6%
TTM-60.3%5Y-180.7%+120.5%
5Y-180.7%10Y-2,844.1%+2,663.4%
1.1.2. Return on Assets

Shows how efficient Optinose is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Optinose to the Drug Manufacturers - Specialty & Generic industry mean.
  • -9.3% Return on Assets means that Optinose generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of OptiNose:

  • The MRQ is -9.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.3%TTM-8.0%-1.2%
TTM-8.0%YOY-15.2%+7.2%
TTM-8.0%5Y-13.6%+5.5%
5Y-13.6%10Y-19.5%+5.9%
1.1.3. Return on Equity

Shows how efficient Optinose is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Optinose to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Optinose generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of OptiNose:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-44.6%+44.6%
5Y-44.6%10Y-32.2%-12.4%

1.2. Operating Efficiency of OptiNose.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Optinose is operating .

  • Measures how much profit Optinose makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Optinose to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -12.6% means the company generated $-0.13  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of OptiNose:

  • The MRQ is -12.6%. The company is operating very inefficient. -2
  • The TTM is -41.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-12.6%TTM-41.4%+28.8%
TTM-41.4%YOY-78.5%+37.1%
TTM-41.4%5Y-152.2%+110.8%
5Y-152.2%10Y-2,800.8%+2,648.5%
1.2.2. Operating Ratio

Measures how efficient Optinose is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.13 means that the operating costs are $1.13 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of OptiNose:

  • The MRQ is 1.126. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.410. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.126TTM1.410-0.283
TTM1.410YOY1.783-0.374
TTM1.4105Y2.536-1.127
5Y2.53610Y39.597-37.061

1.3. Liquidity of OptiNose.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Optinose is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.60 means the company has $0.60 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of OptiNose:

  • The MRQ is 0.597. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.583. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.597TTM0.583+0.013
TTM0.583YOY1.452-0.868
TTM0.5835Y2.889-2.305
5Y2.88910Y4.724-1.836
1.3.2. Quick Ratio

Measures if Optinose is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Optinose to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.53 means the company can pay off $0.53 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of OptiNose:

  • The MRQ is 0.530. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.561. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.530TTM0.561-0.031
TTM0.561YOY1.345-0.784
TTM0.5615Y2.752-2.191
5Y2.75210Y4.207-1.454

1.4. Solvency of OptiNose.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Optinose assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Optinose to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 1.80 means that Optinose assets are financed with 180.4% credit (debt) and the remaining percentage (100% - 180.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of OptiNose:

  • The MRQ is 1.804. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.717. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.804TTM1.717+0.087
TTM1.717YOY1.480+0.237
TTM1.7175Y1.183+0.534
5Y1.18310Y1.000+0.183
1.4.2. Debt to Equity Ratio

Measures if Optinose is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Optinose to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of OptiNose:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y2.707-2.707
5Y2.70710Y1.859+0.848

2. Market Valuation of OptiNose

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Optinose generates.

  • Above 15 is considered overpriced but always compare Optinose to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -3.65 means the investor is paying $-3.65 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of OptiNose:

  • The EOD is -4.182. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.645. Based on the earnings, the company is expensive. -2
  • The TTM is 0.802. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-4.182MRQ-3.645-0.537
MRQ-3.645TTM0.802-4.447
TTM0.802YOY-4.598+5.400
TTM0.8025Y-4.393+5.195
5Y-4.39310Y-5.496+1.102
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of OptiNose:

  • The EOD is 6.097. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 5.315. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -2.537. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD6.097MRQ5.315+0.783
MRQ5.315TTM-2.537+7.851
TTM-2.537YOY-5.067+2.530
TTM-2.5375Y-5.993+3.456
5Y-5.99310Y-7.541+1.548
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Optinose is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of OptiNose:

  • The EOD is -1.925. Based on the equity, the company is expensive. -2
  • The MRQ is -1.678. Based on the equity, the company is expensive. -2
  • The TTM is -2.100. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.925MRQ-1.678-0.247
MRQ-1.678TTM-2.100+0.422
TTM-2.100YOY-5.571+3.471
TTM-2.1005Y7.211-9.311
5Y7.21110Y6.799+0.412
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of OptiNose.

3.1. Institutions holding OptiNose

Institutions are holding 77.615% of the shares of OptiNose.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31FMR Inc13.04890.001514666941-181929-1.2252
2023-12-31MVM Partners LLC12.994110.93991460526300
2023-12-31Great Point Partners LLC7.86471.9436883993900
2023-12-31Nantahala Capital Management, LLC5.59950.24286293842298590090.2646
2023-12-31Rosalind Advisors, Inc.4.34665.1906488558048855800
2023-12-31BlackRock Inc3.91840.000144042512263815.4186
2023-12-31Vanguard Group Inc3.71860.000141797043582319.3742
2023-12-31Bleichroeder LP3.59891.1597404513200
2023-12-31Kingdon Capital Management LLC3.46910.631238992372000005.4065
2023-12-31Velan Capital Investment Management LP3.3782.858837968612000005.5604
2023-12-31Massachusetts Financial Services Company2.53910.0012285392928490.0999
2023-12-31Easterly Investment Partners.1.35350.2098152130926407421.0043
2023-12-31Geode Capital Management, LLC1.29840.00021459354343172.4081
2023-12-31State Street Corporation1.15250.00011295413-22700-1.7222
2023-12-31Rice Hall James & Associates, LLC0.8940.07511004887-45187-4.3032
2023-12-31Northern Trust Corp0.54740.000161528823820.3886
2023-12-31Bank of New York Mellon Corp0.34180.0001384215-6772-1.732
2023-12-31Bridgeway Capital Management, LLC0.30080.009433810000
2023-12-31Springbok Capital Management, LLC0.24020.02312700009000050
2023-12-31GMT Capital Corp0.21430.0117240917-869785-78.3095
Total 70.818823.299179600162+8123341+10.2%

3.2. Funds holding OptiNose

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Fidelity Growth Compy Commingled Pl O5.23780.010358872271114211.9291
2024-01-31Fidelity Growth Company Fund4.24580.0114772288-45325-0.9408
2024-02-29Vanguard Total Stock Mkt Idx Inv2.35090.0003264242800
2024-01-31MFS New Discovery I1.61610.0972181644900
2024-02-29iShares Russell 2000 ETF1.55510.0051747941-286-0.0164
2024-01-31Fidelity Growth Company K61.47630.01251659373-41196-2.4225
2024-01-31Fidelity Series Growth Company1.31190.01251474591-43076-2.8383
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.85040.001795580375940.8009
2024-01-31Fidelity Select Biotechnology0.70640.021779403100
2023-12-31Fidelity Small Cap Index0.60050.003467495900
2024-02-29iShares Russell 2000 Growth ETF0.56990.01640594-745-0.1162
2024-01-31MFS® VIT New Discovery Init0.51750.10558167900
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.38870.001943684700
2024-01-31Fidelity Extended Market Index0.36590.0015411311228405.8795
2023-12-31Bridgeway Ultra-Small Company Market0.24490.191127530000
2024-02-29State St Russell Sm Cap® Indx SL Cl I0.23670.00526610000
2024-02-29Vanguard Russell 2000 ETF0.23290.0049261768206488.5634
2023-09-30BlackRock Extended Mkt Composite0.21490.002124154812760.5311
2024-02-29Pacific Select Small-Cap Growth I0.20270.1484227869-17463-7.1181
Total 22.92530.645525768106+15688+0.1%

3.3. Insider Transactions

Insiders are holding 8.994% of the shares of OptiNose.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-18Anthony J KrickSELL23451.88
2024-03-18Michael F Marino IiiSELL150591.88
2024-03-18Ramy A MahmoudSELL191981.88
2024-01-31Ramy A MahmoudSELL528751.31
2023-12-18Michael F Marino IiiSELL50051.15
2023-12-18Ramy A MahmoudSELL111141.15
2023-09-18Michael F Marino IiiSELL49911.37
2023-09-18Ramy A MahmoudSELL110831.37
2023-06-16Michael F Marino IiiSELL15161.15
2023-06-16Ramy A MahmoudSELL35431.15

4. Summary

4.1. Key Performance Indicators

The key performance indicators of OptiNose compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.080-0.067-17%-0.077-3%-0.091+14%-0.025-69%
Book Value Per Share---0.769-0.683-11%-0.523-32%-0.143-81%0.135-670%
Current Ratio--0.5970.583+2%1.452-59%2.889-79%4.724-87%
Debt To Asset Ratio--1.8041.717+5%1.480+22%1.183+52%1.000+80%
Debt To Equity Ratio----0%-0%2.707-100%1.859-100%
Dividend Per Share----0%-0%0.040-100%0.029-100%
Eps---0.088-0.079-11%-0.166+88%-0.179+102%-0.178+102%
Free Cash Flow Per Share--0.061-0.046+176%-0.150+348%-0.153+351%-0.147+343%
Free Cash Flow To Equity Per Share--0.061-0.046+175%-0.036+159%-0.057+193%0.005+1206%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--8.762--------
Intrinsic Value_10Y_min--7.093--------
Intrinsic Value_1Y_max---0.293--------
Intrinsic Value_1Y_min---0.288--------
Intrinsic Value_3Y_max--0.013--------
Intrinsic Value_3Y_min---0.006--------
Intrinsic Value_5Y_max--1.394--------
Intrinsic Value_5Y_min--1.217--------
Market Cap166724960.000+13%145321080.000159965840.000-9%327817320.000-56%463619306.000-69%609919731.613-76%
Net Profit Margin---0.502-0.603+20%-1.059+111%-1.807+260%-28.441+5569%
Operating Margin---0.126-0.414+227%-0.785+521%-1.522+1104%-28.008+22049%
Operating Ratio--1.1261.410-20%1.783-37%2.536-56%39.597-97%
Pb Ratio-1.925-15%-1.678-2.100+25%-5.571+232%7.211-123%6.799-125%
Pe Ratio-4.182-15%-3.6450.802-555%-4.598+26%-4.393+21%-5.496+51%
Price Per Share1.480+13%1.2901.420-9%2.910-56%4.116-69%5.414-76%
Price To Free Cash Flow Ratio6.097+13%5.315-2.537+148%-5.067+195%-5.993+213%-7.541+242%
Price To Total Gains Ratio-18.544-15%-16.163-3.165-80%-14.543-10%-14.488-10%-14.748-9%
Quick Ratio--0.5300.561-5%1.345-61%2.752-81%4.207-87%
Return On Assets---0.093-0.080-13%-0.152+65%-0.136+47%-0.195+110%
Return On Equity----0%-0%-0.4460%-0.3220%
Total Gains Per Share---0.080-0.067-17%-0.077-3%-0.051-35%0.004-2012%
Usd Book Value---86606000.000-76916500.000-11%-58920000.000-32%-16059500.000-81%15181516.129-670%
Usd Book Value Change Per Share---0.080-0.067-17%-0.077-3%-0.091+14%-0.025-69%
Usd Book Value Per Share---0.769-0.683-11%-0.523-32%-0.143-81%0.135-670%
Usd Dividend Per Share----0%-0%0.040-100%0.029-100%
Usd Eps---0.088-0.079-11%-0.166+88%-0.179+102%-0.178+102%
Usd Free Cash Flow--6836000.000-5215000.000+176%-16928500.000+348%-17190000.000+351%-16614032.258+343%
Usd Free Cash Flow Per Share--0.061-0.046+176%-0.150+348%-0.153+351%-0.147+343%
Usd Free Cash Flow To Equity Per Share--0.061-0.046+175%-0.036+159%-0.057+193%0.005+1206%
Usd Market Cap166724960.000+13%145321080.000159965840.000-9%327817320.000-56%463619306.000-69%609919731.613-76%
Usd Price Per Share1.480+13%1.2901.420-9%2.910-56%4.116-69%5.414-76%
Usd Profit---9967000.000-8822250.000-11%-19253000.000+93%-20221850.000+103%-19354967.742+94%
Usd Revenue--19865000.00017747000.000+12%19069000.000+4%15283200.000+30%13156225.806+51%
Usd Total Gains Per Share---0.080-0.067-17%-0.077-3%-0.051-35%0.004-2012%
 EOD+5 -3MRQTTM+12 -19YOY+14 -175Y+18 -1710Y+16 -19

4.2. Fundamental Score

Let's check the fundamental score of OptiNose based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.182
Price to Book Ratio (EOD)Between0-1-1.925
Net Profit Margin (MRQ)Greater than0-0.502
Operating Margin (MRQ)Greater than0-0.126
Quick Ratio (MRQ)Greater than10.530
Current Ratio (MRQ)Greater than10.597
Debt to Asset Ratio (MRQ)Less than11.804
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.093
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of OptiNose based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.197
Ma 20Greater thanMa 501.744
Ma 50Greater thanMa 1001.529
Ma 100Greater thanMa 2001.382
OpenGreater thanClose1.430
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets107,729
Total Liabilities194,335
Total Stockholder Equity-86,606
 As reported
Total Liabilities 194,335
Total Stockholder Equity+ -86,606
Total Assets = 107,729

Assets

Total Assets107,729
Total Current Assets105,333
Long-term Assets2,396
Total Current Assets
Cash And Cash Equivalents 73,684
Net Receivables 19,926
Inventory 8,052
Other Current Assets 3,671
Total Current Assets  (as reported)105,333
Total Current Assets  (calculated)105,333
+/-0
Long-term Assets
Property Plant Equipment 815
Long-term Assets Other 1,581
Long-term Assets  (as reported)2,396
Long-term Assets  (calculated)2,396
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities176,524
Long-term Liabilities17,811
Total Stockholder Equity-86,606
Total Current Liabilities
Short-term Debt 130,227
Short Long Term Debt 130,227
Accounts payable 3,886
Other Current Liabilities 42,411
Total Current Liabilities  (as reported)176,524
Total Current Liabilities  (calculated)306,751
+/- 130,227
Long-term Liabilities
Capital Lease Obligations 1,522
Long-term Liabilities  (as reported)17,811
Long-term Liabilities  (calculated)1,522
+/- 16,289
Total Stockholder Equity
Common Stock112
Retained Earnings -720,376
Accumulated Other Comprehensive Income -84
Other Stockholders Equity 633,742
Total Stockholder Equity (as reported)-86,606
Total Stockholder Equity (calculated)-86,606
+/-0
Other
Capital Stock112
Cash and Short Term Investments 73,684
Common Stock Shares Outstanding 112,080
Liabilities and Stockholders Equity 107,729
Net Debt 56,543
Net Invested Capital 43,621
Net Working Capital -71,191
Property Plant and Equipment Gross 5,679
Short Long Term Debt Total 130,227



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302015-12-31
> Total Assets 
16,009
0
41,551
63,962
63,962
55,135
241,136
220,562
259,950
237,622
216,989
192,992
166,572
149,377
172,650
174,170
153,048
181,024
188,813
157,946
139,515
131,917
166,071
133,815
122,832
105,270
144,222
114,925
106,068
101,407
107,729
107,729101,407106,068114,925144,222105,270122,832133,815166,071131,917139,515157,946188,813181,024153,048174,170172,650149,377166,572192,992216,989237,622259,950220,562241,13655,13563,96263,96241,551016,009
   > Total Current Assets 
15,817
0
40,675
60,914
60,914
50,320
234,854
217,069
256,054
233,455
200,990
186,782
160,854
144,102
147,144
169,677
148,905
172,437
144,156
150,316
132,594
125,442
160,379
128,419
118,057
100,931
94,244
83,928
103,610
98,620
105,333
105,33398,620103,61083,92894,244100,931118,057128,419160,379125,442132,594150,316144,156172,437148,905169,677147,144144,102160,854186,782200,990233,455256,054217,069234,85450,32060,91460,91440,675015,817
       Cash And Cash Equivalents 
15,198
0
36,797
58,887
58,887
49,410
234,854
209,771
244,990
221,491
200,990
171,316
143,963
125,490
147,144
148,475
125,266
143,134
144,156
115,984
93,916
84,226
110,502
91,367
78,264
61,080
94,244
83,928
71,311
66,845
73,684
73,68466,84571,31183,92894,24461,08078,26491,367110,50284,22693,916115,984144,156143,134125,266148,475147,144125,490143,963171,316200,990221,491244,990209,771234,85449,41058,88758,88736,797015,198
       Short-term Investments 
0
0
0
0
0
0
0
30
13
15
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000001513300000000
       Net Receivables 
448
0
2,422
219
219
231
46
2,320
3,882
3,105
2,552
5,917
9,601
10,978
13,818
11,733
14,096
17,524
23,394
17,958
20,715
24,088
35,449
22,702
25,766
26,616
33,932
16,979
22,128
21,373
19,926
19,92621,37322,12816,97933,93226,61625,76622,70235,44924,08820,71517,95823,39417,52414,09611,73313,81810,9789,6015,9172,5523,1053,8822,320462312192192,4220448
       Other Current Assets 
171
0
255
1,808
409
438
1,254
1,398
2,232
1,850
15,999
3,833
3,030
3,230
3,614
3,760
3,418
2,453
4,060
3,671
4,660
3,967
2,581
2,970
3,054
2,820
2,865
2,961
2,439
2,359
3,671
3,6712,3592,4392,9612,8652,8203,0542,9702,5813,9674,6603,6714,0602,4533,4183,7603,6143,2303,0303,83315,9991,8502,2321,3981,2544384091,8082550171
   > Long-term Assets 
0
0
876
0
3,048
4,815
6,282
3,493
3,896
4,167
15,999
6,210
5,718
5,275
25,506
4,493
4,143
8,587
44,657
7,630
6,921
6,475
5,692
5,396
4,775
4,339
49,978
30,997
2,458
2,787
2,396
2,3962,7872,45830,99749,9784,3394,7755,3965,6926,4756,9217,63044,6578,5874,1434,49325,5065,2755,7186,21015,9994,1673,8963,4936,2824,8153,048087600
       Property Plant Equipment 
191
0
323
1,142
1,142
1,433
2,564
3,102
3,596
3,957
3,884
3,715
3,531
3,261
3,052
2,980
2,790
2,408
2,028
1,885
1,685
1,515
1,347
1,218
1,063
901
795
722
723
882
815
8158827237227959011,0631,2181,3471,5151,6851,8852,0282,4082,7902,9803,0523,2613,5313,7153,8843,9573,5963,1022,5641,4331,1421,1423230191
       Long-term Assets Other 
0
0
553
0
1,906
3,382
3,718
391
300
210
12,115
2,495
2,187
2,014
22,454
1,513
1,353
6,179
42,629
5,745
5,236
4,960
4,345
4,178
3,712
3,438
49,183
30,275
1,735
1,905
1,581
1,5811,9051,73530,27549,1833,4383,7124,1784,3454,9605,2365,74542,6296,1791,3531,51322,4542,0142,1872,49512,1152103003913,7183,3821,906055300
> Total Liabilities 
22,342
0
45,389
6,225
6,225
68,568
86,640
94,451
95,618
94,892
98,378
100,639
98,100
104,859
111,067
139,039
140,439
153,341
182,025
174,613
176,588
183,386
187,843
178,673
183,615
178,686
200,845
188,710
175,728
179,022
194,335
194,335179,022175,728188,710200,845178,686183,615178,673187,843183,386176,588174,613182,025153,341140,439139,039111,067104,85998,100100,63998,37894,89295,61894,45186,64068,5686,2256,22545,389022,342
   > Total Current Liabilities 
7,193
0
5,910
6,225
6,225
9,699
14,777
22,488
23,213
22,362
25,697
26,868
24,367
29,962
36,139
34,225
34,898
43,350
52,172
44,781
46,798
53,627
59,235
50,023
55,038
177,795
178,729
166,303
164,299
163,981
176,524
176,524163,981164,299166,303178,729177,79555,03850,02359,23553,62746,79844,78152,17243,35034,89834,22536,13929,96224,36726,86825,69722,36223,21322,48814,7779,6996,2256,2255,91007,193
       Short-term Debt 
14,480
0
15,256
15,256
0
5,237
71,863
71,963
72,138
0
0
1,510
1,448
1,390
1,135
1,346
1,256
1,904
2,108
2,131
2,124
2,109
2,094
2,314
2,356
130,353
130,546
130,623
130,794
130,944
130,227
130,227130,944130,794130,623130,546130,3532,3562,3142,0942,1092,1242,1312,1081,9041,2561,3461,1351,3901,4481,5100072,13871,96371,8635,237015,25615,256014,480
       Short Long Term Debt 
14,480
0
15,256
15,256
0
0
71,863
71,963
72,138
0
0
1,510
0
0
0
0
0
0
0
0
0
0
0
0
0
128,107
128,575
128,979
129,394
129,813
130,227
130,227129,813129,394128,979128,575128,10700000000000001,5100072,13871,96371,8630015,25615,256014,480
       Accounts payable 
3,506
0
3,369
2,311
2,311
3,876
5,893
7,996
6,951
6,549
7,116
7,676
2,811
5,112
3,625
5,403
3,505
6,069
5,489
7,973
3,471
6,502
8,013
7,642
9,829
8,403
5,291
6,244
6,482
5,006
3,886
3,8865,0066,4826,2445,2918,4039,8297,6428,0136,5023,4717,9735,4896,0693,5055,4033,6255,1122,8117,6767,1166,5496,9517,9965,8933,8762,3112,3113,36903,506
       Other Current Liabilities 
3,687
0
2,541
133
3,781
369
8,698
14,492
16,254
15,645
18,421
1,510
21,556
24,850
32,514
28,822
31,393
37,281
46,683
34,677
41,203
47,125
49,128
40,067
42,853
39,039
42,892
29,436
28,423
29,162
42,411
42,41129,16228,42329,43642,89239,03942,85340,06749,12847,12541,20334,67746,68337,28131,39328,82232,51424,85021,5561,51018,42115,64516,25414,4928,6983693,7811332,54103,687
   > Long-term Liabilities 
0
0
39,479
0
0
58,869
71,863
71,963
72,405
72,530
72,681
73,771
73,733
74,897
74,928
104,814
105,541
109,991
129,853
129,832
129,790
129,759
128,608
128,650
128,577
891
22,116
22,407
11,429
15,041
17,811
17,81115,04111,42922,40722,116891128,577128,650128,608129,759129,790129,832129,853109,991105,541104,81474,92874,89773,73373,77172,68172,53072,40571,96371,86358,8690039,47900
       Long term Debt Total 
0
0
0
0
0
0
71,863
71,963
72,138
72,318
72,500
72,680
72,869
74,266
74,531
104,656
104,947
105,013
125,202
125,584
126,043
126,542
126,418
126,954
127,483
0
0
0
0
0
0
000000127,483126,954126,418126,542126,043125,584125,202105,013104,947104,65674,53174,26672,86972,68072,50072,31872,13871,96371,863000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
1,510
1,448
1,390
1,135
1,346
1,256
1,904
2,108
2,131
2,124
2,109
4,284
2,314
2,356
2,246
2,596
1,644
1,400
1,131
1,522
1,5221,1311,4001,6442,5962,2462,3562,3144,2842,1092,1242,1312,1081,9041,2561,3461,1351,3901,4481,51000000000000
       Warrants
0
0
0
0
0
473,084
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000473,08400000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
267
212
0
1,091
864
631
397
158
594
4,978
4,651
4,248
3,747
3,217
2,190
1,696
1,094
891
22,116
22,407
11,429
741
0
074111,42922,40722,1168911,0941,6962,1903,2173,7474,2484,6514,9785941583976318641,091021226700000000
       Deferred Long Term Liability 
0
0
0
1,567
1,567
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000001,5671,567000
> Total Stockholder Equity
-161,392
0
-3,838
-151,197
57,737
-13,433
154,496
126,111
164,332
142,730
118,611
92,353
68,472
44,518
61,583
35,131
12,609
27,683
6,788
-16,667
-37,073
-51,469
-21,772
-44,858
-60,783
-73,416
-56,623
-73,785
-69,660
-77,615
-86,606
-86,606-77,615-69,660-73,785-56,623-73,416-60,783-44,858-21,772-51,469-37,073-16,6676,78827,68312,60935,13161,58344,51868,47292,353118,611142,730164,332126,111154,496-13,43357,737-151,197-3,8380-161,392
   Common Stock
4
0
4
1
29
4
38
38
41
41
41
41
41
41
46
46
46
52
53
53
53
53
82
83
83
84
111
112
112
112
112
11211211211211184838382535353535246464641414141414138384291404
   Retained Earnings -720,376-710,408-701,114-703,740-684,893-669,745-654,791-635,394-610,061-594,437-577,320-553,818-527,765-503,902-482,688-456,836-427,980-402,985-374,178-346,801-317,927-291,546-266,423-241,841-211,269-191,001-174,580-174,577-151,1020-161,252
   Capital Surplus 
0
0
0
0
0
0
365,838
368,018
430,803
434,312
436,554
439,167
442,676
447,541
489,565
491,994
495,329
531,598
534,585
537,181
540,277
542,996
588,288
590,535
594,009
596,329
628,242
629,927
631,426
0
0
00631,426629,927628,242596,329594,009590,535588,288542,996540,277537,181534,585531,598495,329491,994489,565447,541442,676439,167436,554434,312430,803368,018365,838000000
   Treasury Stock0000000000000000000000000000000
   Other Stockholders Equity 
-141
0
275
-105
232,728
357
366,082
368,419
431,407
435,166
437,648
440,546
444,333
449,461
491,764
494,399
498,017
534,826
534,585
537,181
540,277
542,996
588,288
590,535
594,009
596,329
628,243
629,927
631,426
632,765
633,742
633,742632,765631,426629,927628,243596,329594,009590,535588,288542,996540,277537,181534,585534,826498,017494,399491,764449,461444,333440,546437,648435,166431,407368,419366,082357232,728-1052750-141



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue70,987
Cost of Revenue-9,035
Gross Profit61,95261,952
 
Operating Income (+$)
Gross Profit61,952
Operating Expense-84,700
Operating Income-22,748-22,748
 
Operating Expense (+$)
Research Development5,303
Selling General Administrative79,799
Selling And Marketing Expenses0
Operating Expense84,70085,102
 
Net Interest Income (+$)
Interest Income2,527
Interest Expense-19,528
Other Finance Cost-0
Net Interest Income-17,001
 
Pretax Income (+$)
Operating Income-22,748
Net Interest Income-17,001
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-35,483-10,013
EBIT - interestExpense = -42,276
-35,483
-15,955
Interest Expense19,528
Earnings Before Interest and Taxes (EBIT)-22,748-15,955
Earnings Before Interest and Taxes (EBITDA)-22,346
 
After tax Income (+$)
Income Before Tax-35,483
Tax Provision-0
Net Income From Continuing Ops-35,483-35,483
Net Income-35,483
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses93,735
Total Other Income/Expenses Net-12,73517,001
 

Technical Analysis of Optinose
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Optinose. The general trend of Optinose is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Optinose's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of OptiNose.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.62 < 1.9491 < 2.04.

The bearish price targets are: 1.3995 > 1.2 > 1.16.

Tweet this
OptiNose Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of OptiNose. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

OptiNose Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of OptiNose. The current macd is 0.00199865.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Optinose price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Optinose. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Optinose price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
OptiNose Daily Moving Average Convergence/Divergence (MACD) ChartOptiNose Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of OptiNose. The current adx is 23.30.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Optinose shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
OptiNose Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of OptiNose. The current sar is 1.98997621.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
OptiNose Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of OptiNose. The current rsi is 39.20. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
OptiNose Daily Relative Strength Index (RSI) ChartOptiNose Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of OptiNose. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Optinose price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
OptiNose Daily Stochastic Oscillator ChartOptiNose Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of OptiNose. The current cci is -170.69734764.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
OptiNose Daily Commodity Channel Index (CCI) ChartOptiNose Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of OptiNose. The current cmo is -39.89359218.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
OptiNose Daily Chande Momentum Oscillator (CMO) ChartOptiNose Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of OptiNose. The current willr is -92.53731343.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
OptiNose Daily Williams %R ChartOptiNose Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of OptiNose.

OptiNose Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of OptiNose. The current atr is 0.13861886.

OptiNose Daily Average True Range (ATR) ChartOptiNose Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of OptiNose. The current obv is -10,501,061.

OptiNose Daily On-Balance Volume (OBV) ChartOptiNose Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of OptiNose. The current mfi is 36.04.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
OptiNose Daily Money Flow Index (MFI) ChartOptiNose Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for OptiNose.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-24MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

OptiNose Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of OptiNose based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.197
Ma 20Greater thanMa 501.744
Ma 50Greater thanMa 1001.529
Ma 100Greater thanMa 2001.382
OpenGreater thanClose1.430
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Optinose with someone you think should read this too:
  • Are you bullish or bearish on Optinose? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Optinose? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about OptiNose

I send you an email if I find something interesting about OptiNose.


Comments

How you think about this?

Leave a comment

Stay informed about OptiNose.

Receive notifications about OptiNose in your mailbox!